COVID-19

Community Research Initiative (CRI) is closely monitioring the situation around COVID-19. The safety of our clients, supporters and staff is of paramount importance to us. 

As things continue to evolve we have been working closely with the Department of Public Health (DPH) to ensure our clients receive essential coverage and care during these uncertain times.

HIV Drug Assistance Program (HDAP) & Comprehensive Health Insurance Initiative (CHII) Updates in response to COVID-19

In response to Massachusetts Governor Baker's declaration of a State of Emergency to Respond to COVID-19 and to ensure that HDAP clients do not experience a gap in coverage or treatment access during this public health emergency, modifications are being made to HDAP screening and enrollment procedures, effective immediately.

As of 9/16/20: Effective immediately, clients due to recertify in HDAP on September 30th and beyond will be subject to HDAP’s standard screening and enrollment procedures consistent with the ongoing phased reopening. All clients due to recertify in HDAP must submit a complete application that they are eligible for during this cycle (short or long form) with the required documentation. Clients who do not submit the appropriate application by their recertification date will term out of the program until their application is received and approved.

Please visit our Rapid Enrollment Page to learn more

HPDAP/CHII Updates for patients who have lost work-sponsored insurance

A Message to Pharmacies - COVID-19 and HDAP

Pre-Exposure Prophylaxis Drug Assistance Program (PrEPDAP) 

To ensure that PrEPDAP clients do not experience a gap in coverage or access to medications or pre-exposure prophylaxis (PrEP) during this public health emergency, modifications such as extensions, early prescription refills and 60/90 day prescription refills are being made to PrEPDAP procedures and coverage, effective immediately.   

Please visit our PrEPDAP and COVID-19 Page to learn more

Additional Online Resources